AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
EVALUATION OF STEM-CELL TRANSPLANTATION IN AML
Authors: BURNETT AK GOLDSTONE A HANN I STEVENS R REES JKH WHEATLEY K
Citation: Ak. Burnett et al., EVALUATION OF STEM-CELL TRANSPLANTATION IN AML, Leukemia & lymphoma (Print), 30, 1998, pp. 29-29
WHICH CONSOLIDATION THERAPY IN 2ND REMISSION (CR-2) FOR CHILDREN WITHRELAPSED AML
Authors: WEBB DKH WHEATLEY K STEVENS RF HANN IM
Citation: Dkh. Webb et al., WHICH CONSOLIDATION THERAPY IN 2ND REMISSION (CR-2) FOR CHILDREN WITHRELAPSED AML, Bone marrow transplantation, 21, 1998, pp. 18-18
RANDOMIZED COMPARISON OF ADDITION OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION TO INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION - RESULTS OF MRC AML-10 TRIAL
Authors: BURNETT AK GOLDSTONE AH STEVENS RMF HANN IM REES JKH GRAY RG WHEATLEY K
Citation: Ak. Burnett et al., RANDOMIZED COMPARISON OF ADDITION OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION TO INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION - RESULTS OF MRC AML-10 TRIAL, Lancet, 351(9104), 1998, pp. 700-708
A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA
Authors: WHEATLEY D DUTCHER JP WIERNIK PH HUGUET F POLIN V REIFFERS J SOTTO JJ STOPPA AM MANDELLI F PETTI MC HAROUSSEAU JL MERCIER M POLIN V TELLIER Z BERMAN E STAGG M VOGLER WR BEZWODA WR ALISON R CLARKE M EVANS V GRAY R GREAVES E HALL E HICKS C JAMES S PETO R RICHARDS S SINCLAIR D TOOTH A WHEATLEY K
Citation: D. Wheatley et al., A SYSTEMATIC COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS COMPARING IDARUBICIN WITH DAUNORUBICIN (OR OTHER ANTHRACYCLINES) AS INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 103(1), 1998, pp. 100-109
SURVEY OF THE USE OF PLATELET TRANSFUSIONS IN CENTERS PARTICIPATING IN MRC LEUKEMIA TRIALS
Authors: MURPHY MF WHEATLEY K GOLDSTONE AH
Citation: Mf. Murphy et al., SURVEY OF THE USE OF PLATELET TRANSFUSIONS IN CENTERS PARTICIPATING IN MRC LEUKEMIA TRIALS, British Journal of Haematology, 102(3), 1998, pp. 875-876
WHICH MYELOMA PATIENTS BENEFIT FROM INTERFERON THERAPY - AN OVERVIEW OF 24 RANDOMIZED TRIALS WITH 4000 PATIENTS
Authors: WHEATLEY K
Citation: K. Wheatley, WHICH MYELOMA PATIENTS BENEFIT FROM INTERFERON THERAPY - AN OVERVIEW OF 24 RANDOMIZED TRIALS WITH 4000 PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 140-140
ASSOCIATION BETWEEN REPRODUCIBLE FLOW CYTOMETRIC METHODOLOGY FOR MEASURING MULTIDRUG-RESISTANCE AND REMISSION RATES IN AML
Authors: PALLIS M TURZANSKI J HARRISON G WHEATLEY K LANGABEER S BURNETT AK RUSSELL NH
Citation: M. Pallis et al., ASSOCIATION BETWEEN REPRODUCIBLE FLOW CYTOMETRIC METHODOLOGY FOR MEASURING MULTIDRUG-RESISTANCE AND REMISSION RATES IN AML, British Journal of Haematology, 102(1), 1998, pp. 331-331
MARKED IMPROVEMENTS IN OUTCOME WITH CHEMOTHERAPY ALONE IN PEDIATRIC ACUTE MYELOID-LEUKEMIA - RESULTS OF THE UNITED-KINGDOM MEDICAL-RESEARCHCOUNCILS 10TH AML TRIAL
Authors: STEVENS RF HANN IM WHEATLEY K GRAY RG
Citation: Rf. Stevens et al., MARKED IMPROVEMENTS IN OUTCOME WITH CHEMOTHERAPY ALONE IN PEDIATRIC ACUTE MYELOID-LEUKEMIA - RESULTS OF THE UNITED-KINGDOM MEDICAL-RESEARCHCOUNCILS 10TH AML TRIAL, British Journal of Haematology, 101(1), 1998, pp. 130-140
THE ROLE OF MOLECULAR DIAGNOSIS AND RESIDUAL DISEASE MONITORING IN APL - RESULTS OF THE MRC ATRA TRIAL
Authors: GRIMWADE D LANGABEER S HOWE K WALKER H WHEATLEY K HARRISON G GOLDSTONE A BURNETT A SOLOMON E
Citation: D. Grimwade et al., THE ROLE OF MOLECULAR DIAGNOSIS AND RESIDUAL DISEASE MONITORING IN APL - RESULTS OF THE MRC ATRA TRIAL, British Journal of Haematology, 101, 1998, pp. 322-322
THE IMPORTANCE OF DIAGNOSTIC CYTOGENETICS ON OUTCOME IN AML - ANALYSIS OF 1,612 PATIENTS ENTERED INTO THE MRC-AML-10 TRIAL
Authors: GRIMWADE D WALKER H OLIVER F WHEATLEY K HARRISON C HARRISON G REES J HANN I STEVENS R BURNETT A GOLDSTONE A
Citation: D. Grimwade et al., THE IMPORTANCE OF DIAGNOSTIC CYTOGENETICS ON OUTCOME IN AML - ANALYSIS OF 1,612 PATIENTS ENTERED INTO THE MRC-AML-10 TRIAL, Blood, 92(7), 1998, pp. 2322-2333
INTERFERON-ALFA VERSUS CHEMOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA - A METAANALYSIS OF 7 RANDOMIZED TRIALS
Authors: DELANNOY A KLUINNELEMANS JC LOUWAGIE A STRYCKMANNS P SUCIU S HEHLMANN R HEIMPEL H HASFORD J ZUFFA E BACCARANI M TURA S OHNISHI K OHNO R ALLAN N SHEPHERD P BROUSTET A ALISON R CLARKE M DUONG H GRAY R GREAVES E PETO R RICHARDS S SINCLAIR D WHEATLEY K
Citation: A. Delannoy et al., INTERFERON-ALFA VERSUS CHEMOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA - A METAANALYSIS OF 7 RANDOMIZED TRIALS, Journal of the National Cancer Institute, 89(21), 1997, pp. 1616-1620
WHAT HAPPENS SUBSEQUENTLY IN AML WHEN CYTOGENETIC ABNORMALITIES PERSIST AT BONE-MARROW HARVEST - RESULTS OF THE 10TH UK MRC AML TRIAL
Authors: GRIMWADE D WALKER H OLIVER F WHEATLEY K CLACK R BURNETT A GOLDSTONE A
Citation: D. Grimwade et al., WHAT HAPPENS SUBSEQUENTLY IN AML WHEN CYTOGENETIC ABNORMALITIES PERSIST AT BONE-MARROW HARVEST - RESULTS OF THE 10TH UK MRC AML TRIAL, Bone marrow transplantation, 19(11), 1997, pp. 1117-1123
ALCOHOL AND CORONARY HEART-DISEASE REDUCTION AMONG BRITISH DOCTORS - CONFOUNDING OR CAUSALITY
Authors: DOLL R PETO R HALL E WHEATLEY K GRAY R
Citation: R. Doll et al., ALCOHOL AND CORONARY HEART-DISEASE REDUCTION AMONG BRITISH DOCTORS - CONFOUNDING OR CAUSALITY, European heart journal, 18(1), 1997, pp. 23-25
PRINT POLITICS - THE PRESS AND RADICAL OPPOSITION IN EARLY 19TH-CENTURY ENGLAND - GILMARTIN,K
Authors: WHEATLEY K
Citation: K. Wheatley, PRINT POLITICS - THE PRESS AND RADICAL OPPOSITION IN EARLY 19TH-CENTURY ENGLAND - GILMARTIN,K, Wordsworth circle, 28(4), 1997, pp. 231-233
INCIDENCE OF AML1 ETO FUSION TRANSCRIPTS IN PATIENTS ENTERED INTO THEMRC AML TRIALS/
Authors: LANGABEER SE WALKER H ROGERS JR BURNETT AK WHEATLEY K SWIRSKY D GOLDSTONE AH LINCH DC
Citation: Se. Langabeer et al., INCIDENCE OF AML1 ETO FUSION TRANSCRIPTS IN PATIENTS ENTERED INTO THEMRC AML TRIALS/, British Journal of Haematology, 99(4), 1997, pp. 925-928
FREQUENCY OF CBF-BETA MYH11 FUSION TRANSCRIPTS IN PATIENTS ENTERED INTO THE UK MRC AML TRIALS/
Authors: LANGABEER SE WALKER H GALE RE WHEATLEY K BURNETT AK GOLDSTONE AH LINCH DC
Citation: Se. Langabeer et al., FREQUENCY OF CBF-BETA MYH11 FUSION TRANSCRIPTS IN PATIENTS ENTERED INTO THE UK MRC AML TRIALS/, British Journal of Haematology, 96(4), 1997, pp. 736-739
MOLECULAR CHARACTERIZATION OF PATIENTS WITH APL ENTERED INTO THE UK MRC ATRA TRIAL - RELATIONSHIP OF PML BREAKPOINT WITH ADDITIONAL CYTOGENETIC ABNORMALITIES AND OUTCOME
Authors: GRIMWADE D LANGABEER S GORMAN P HOWE K DUPREZ E WALKER H WHEATLEY K GOLDSTONE A BURNETT A SOLOMON E
Citation: D. Grimwade et al., MOLECULAR CHARACTERIZATION OF PATIENTS WITH APL ENTERED INTO THE UK MRC ATRA TRIAL - RELATIONSHIP OF PML BREAKPOINT WITH ADDITIONAL CYTOGENETIC ABNORMALITIES AND OUTCOME, Blood, 90(10), 1997, pp. 271-271
ALL TRANSRETINOIC ACID GIVEN CONCURRENTLY WITH INDUCTION CHEMOTHERAPYIMPROVES THE OUTCOME OF APL - RESULTS OF THE UK MRC ATRA TRIAL
Authors: BURNETT AK GOLDSTONE AH GRAY RG WHEATLEY K
Citation: Ak. Burnett et al., ALL TRANSRETINOIC ACID GIVEN CONCURRENTLY WITH INDUCTION CHEMOTHERAPYIMPROVES THE OUTCOME OF APL - RESULTS OF THE UK MRC ATRA TRIAL, Blood, 90(10), 1997, pp. 1474-1474
OUTCOME OF ACUTE MYELOID LEUKEMIAS AFFECTING CORE BINDING-FACTOR SUBUNITS - THE UK MRC EXPERIENCE
Authors: BURNETT AK WHEATLEY K LANGABEER S WALKER H LINCH D GOLDSTONE AH HANN I STEVENS RF
Citation: Ak. Burnett et al., OUTCOME OF ACUTE MYELOID LEUKEMIAS AFFECTING CORE BINDING-FACTOR SUBUNITS - THE UK MRC EXPERIENCE, Blood, 90(10), 1997, pp. 1737-1737
LACK OF BENEFIT OF G-CSF ON COMPLETE REMISSION AND POSSIBLE INCREASEDRELAPSE RISK IN AML - AN MRC STUDY OF 800 PATIENTS
Authors: GOLDSTONE AH BURNETT AK MILLIGAN DW PRENTICE AG WHEATLEY K
Citation: Ah. Goldstone et al., LACK OF BENEFIT OF G-CSF ON COMPLETE REMISSION AND POSSIBLE INCREASEDRELAPSE RISK IN AML - AN MRC STUDY OF 800 PATIENTS, Blood, 90(10), 1997, pp. 2595-2595
RANDOMIZED COMPARISON OF DAT VERSUS ADE AS INDUCTION CHEMOTHERAPY IN CHILDREN AND YOUNGER ADULTS WITH ACUTE MYELOID-LEUKEMIA - RESULTS OF THE MEDICAL-RESEARCH COUNCILS 10TH AML TRIAL (MRC AML10)
Authors: HANN IM STEVENS RF GOLDSTONE AH REES JKH WHEATLEY K GRAY RG BURNETT AK
Citation: Im. Hann et al., RANDOMIZED COMPARISON OF DAT VERSUS ADE AS INDUCTION CHEMOTHERAPY IN CHILDREN AND YOUNGER ADULTS WITH ACUTE MYELOID-LEUKEMIA - RESULTS OF THE MEDICAL-RESEARCH COUNCILS 10TH AML TRIAL (MRC AML10), Blood, 89(7), 1997, pp. 2311-2318
THE IMPACT OF ACUTE MYELOID-LEUKEMIA TREATMENTS ON SEXUAL FUNCTIONINGAND FERTILITY
Authors: WATSON M WHEATLEY K HALL E BURNETT AK CONNOLLY N GOLDSTONE AH REES JK GRAY RG ZITTOUN R
Citation: M. Watson et al., THE IMPACT OF ACUTE MYELOID-LEUKEMIA TREATMENTS ON SEXUAL FUNCTIONINGAND FERTILITY, Psycho-oncology, 5(4), 1996, pp. 362-362
A MODULAR QUESTIONNAIRE FOR THE ASSESSMENT OF LONG-TERM QUALITY-OF-LIFE IN LEUKEMIA PATIENTS - THE MRC EORTC QLQ-LEU/
Authors: WATSON M ZITTOUN R HALL E SOLBU G WHEATLEY K
Citation: M. Watson et al., A MODULAR QUESTIONNAIRE FOR THE ASSESSMENT OF LONG-TERM QUALITY-OF-LIFE IN LEUKEMIA PATIENTS - THE MRC EORTC QLQ-LEU/, Quality of life research, 5(1), 1996, pp. 15-19
OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS
Authors: CLARKE M COLLINS R DAVIES C GODWIN J GRAY R PETO R ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M VANDEVELDE AO VANDONGEN JA VERMORKEN JB ARVELAKIS A GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP PEEK U OATES GD POWELL J BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL CIRRINCIONE C KORZUN A WEISS RB WOOD WC BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A HORGAN K HUGHES L STEWART HJ GORDON NH DAVIS HL LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ ABELOFF MD CARBONE PC GLICK J TORMEY DC ROSSBACH J SCANLON EF SCHURMAN S DESCHRYVER A YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLEFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVALLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S TASUTOMI T SONOO H YAMASHITA J OGAWA M HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S AHMANN D SCHAID DJ BUZDAR AU SMITH T HAKES T NORTON L WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM BROWN A FISHER B REDMOND C WOLMARK N JACKSON IM PALMER MK INGLE JN SUMAN VJ BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR NAKAMURA Y MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MYLES JD PATER JL PRITCHARD KI MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST A CROSSLEY E DURRANT K HARRIS A BEIGHTON A COLLINS R EVANS V GREAVES E HARWOOD C JAMES S LAU E MEAD G MULDAL A NAUGHTON A TOOTH A WHEATLEY K RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPEILMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CJ ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P HOST H BRYANT AJS EWING GH KRUSHENKOSLOSKI JL FORREST APM JACK W MCDONALD C MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC JAKESZ R GNANT M BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: M. Clarke et al., OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 348(9036), 1996, pp. 1189-1196
DURATION AND INTENSITY OF MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA - OVERVIEW OF 42 TRIALS INVOLVING 12,000 RANDOMIZED CHILDREN
Authors: RICHARDS S GRAY R PETO R GAYNON P MASERA G PESSION A RONDELLI R VALSECCHI MG REITER A RIEHM H SCHRAPPE M MCINTYRE OR BLEYER A CAIRO M REAMAN G SATHER H TRIGG M AUCLERC MF BANCILLON A LEPAGE E SCHAISON G CLAVELL L DATTON V DONNELLY M GELBER R SALLAN SE SACKMANMURIEL F SANTARELLI MT PEREZ C SOLIDORO A BAILEY C BURNETT A CHESSELLS J EDEN OB GORDONSMITH EC LILLEYMAN J LAND VJ MAHONEY D MURPHY S STEUBER CP VIETTI T CRIST W HANCOCK M PUI CH SIMONE J MITTRA I SHETTY PA ALLISON R BAIGENT C CLARKE M DUONG H DURRANT J GODWIN J GREAVES E HARWOOD C PETO J SINCLAIR D WHEATLEY K
Citation: S. Richards et al., DURATION AND INTENSITY OF MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA - OVERVIEW OF 42 TRIALS INVOLVING 12,000 RANDOMIZED CHILDREN, Lancet, 347(9018), 1996, pp. 1783-1788
Risultati: 1-25 | 26-48